AAR’s strategic acquisition of HAECO Americas represents more than just expansion—it’s a calculated move to dominate North American heavy maintenance during an unprecedented capacity crunch. The $78 million deal brings immediate scale and workforce advantages in a constrained market.
A new lawsuit alleges Spotify profits from fake streams that cost artists hundreds of millions. The case reveals systemic flaws in how streaming platforms handle artificial inflation and revenue distribution.
Xbox’s packed November week showcases Microsoft’s dual strategy of Game Pass day-one releases alongside premium-priced standalone titles. This approach tests whether players will embrace both subscription value and high-price purchases simultaneously.
China now dominates AI patent filings and model downloads while closing the talent gap with the US. But semiconductor restrictions and different development approaches create a complex competitive landscape that defies simple “winner” narratives.
As AI data centers consume unprecedented electricity, a specialized ETF focused on power infrastructure has surged 33% year-to-date, nearly doubling the S&P 500’s performance. The real AI winners might not be the tech companies building models, but the companies powering them.
After two decades of near-constant losses, Reddit’s CEO has joined the billionaire ranks. His secret weapon? Making Reddit indispensable to AI companies hungry for authentic human conversation data.
According to Forbes, Reddit cofounder and CEO Steve Huffman has achieved billionaire status with a
A landmark Supreme Court case challenging presidential tariff authority threatens to rewrite constitutional tax powers and disrupt decades of trade policy. The outcome could fundamentally alter how Congress delegates taxing authority to the executive branch.
Rockstar spent years trying to solve the open-world spy game puzzle before admitting defeat. The core tension between narrative urgency and player freedom creates a design paradox that continues to challenge the industry.
Stockholm-based BOOST Pharma has raised €3.1 million to accelerate development of its pioneering stem cell therapy for osteogenesis imperfecta. The funding reflects growing European investment in advanced cell therapies targeting rare pediatric diseases with early intervention strategies.
China’s renewable energy capacity is growing at unprecedented rates, but outdated grid infrastructure and market systems threaten to undermine decarbonization efforts. The world’s largest polluter faces a critical transition challenge that could determine global climate outcomes.
